_id
690f375dccc777a4e85d17de
Ticker
BNYN
Name
Banyan Corp
Exchange
OTCCE
Address
9025 Wilshire Boulevard, Beverly Hills, CA, United States, 90211
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
-
Description
Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.
Last Close
-
Volume
5
Current Price
0.0002
Change
0
Last Updated
2026-01-20T16:50:39.599Z
Image
-
Ipo Date
-
Market Cap
4544
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2008-06-30
Revenue
696364
Cost Of Revenue
0
Gross Profit
696364
Operating Expenses
884490
Operating Income
-188126
Interest Expense
656096
Pretax Income
-849101
Net Income
-849101
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
0
EBITDA
-
Operating Margin
-27.01546892142615
Total Other Income Expense Net
-660975
Cash
66582
Short Term Investments
-
Receivables
1201522
Inventories
-
Total Current Assets
1299860
Property Plant Equipment
46748
Total Assets
3759657
Payables
399037
Short Term Debt
2011423
Long Term Debt
1536631
Total Liabilities
5451709
Equity
-1692052
Bs_currency_symbol
USD
Depreciation
11342
Change In Working Capital
-
Cash From Operations
256834
Capital Expenditures
1108
Cash From Investing
-1108
Cash From Financing
-230448
Net Change In Cash
25278
Cf_currency_symbol
USD
PE
-
PB
-
ROE
50.18173200350816
ROA
-22.58453364229769
FCF
255726
Fcf Percent
0.36723035653767283
Piotroski FScore
2
Health Score
60
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
8.3
Garp Investing Score
5.5
Growth Investing Score
5.5
Momentum Investing Score
3.5
Net Net Investing Score
3.5
Quality Investing Score
4.5
Value Investing Score
3
Quarters > 0 > quarter
2008-06-30
Quarters > 0 > income Statement > revenue
696364
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
696364
Quarters > 0 > income Statement > operating Expenses
884490
Quarters > 0 > income Statement > operating Income
-188126
Quarters > 0 > income Statement > interest Expense
656096
Quarters > 0 > income Statement > pretax Income
-849101
Quarters > 0 > income Statement > net Income
-849101
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-27.01546892142615
Quarters > 0 > income Statement > total Other Income Expense Net
-660975
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
66582
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1201522
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1299860
Quarters > 0 > balance Sheet > property Plant Equipment
46748
Quarters > 0 > balance Sheet > total Assets
3759657
Quarters > 0 > balance Sheet > payables
399037
Quarters > 0 > balance Sheet > short Term Debt
2011423
Quarters > 0 > balance Sheet > long Term Debt
1536631
Quarters > 0 > balance Sheet > total Liabilities
5451709
Quarters > 0 > balance Sheet > equity
-1692052
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-849101
Quarters > 0 > cash Flow > depreciation
11342
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
256834
Quarters > 0 > cash Flow > capital Expenditures
1108
Quarters > 0 > cash Flow > cash From Investing
-1108
Quarters > 0 > cash Flow > cash From Financing
-230448
Quarters > 0 > cash Flow > net Change In Cash
25278
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
50.18173200350816
Quarters > 0 > ratios > ROA
-22.58453364229769
Quarters > 0 > ratios > FCF
255726
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.36723035653767283
Quarters > 0 > health Score
60
Quarters > 1 > quarter
2008-03-31
Quarters > 1 > income Statement > revenue
574557
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
574557
Quarters > 1 > income Statement > operating Expenses
978938
Quarters > 1 > income Statement > operating Income
-404381
Quarters > 1 > income Statement > interest Expense
653901
Quarters > 1 > income Statement > pretax Income
-981063
Quarters > 1 > income Statement > net Income
-981063
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-70.38135467847403
Quarters > 1 > income Statement > total Other Income Expense Net
-576682
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
41304
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1540873
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1623794
Quarters > 1 > balance Sheet > property Plant Equipment
51397
Quarters > 1 > balance Sheet > total Assets
4111277
Quarters > 1 > balance Sheet > payables
372704
Quarters > 1 > balance Sheet > short Term Debt
1550382
Quarters > 1 > balance Sheet > long Term Debt
1411073
Quarters > 1 > balance Sheet > total Liabilities
5042106
Quarters > 1 > balance Sheet > equity
-930829
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-981063
Quarters > 1 > cash Flow > depreciation
10788
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
75075
Quarters > 1 > cash Flow > capital Expenditures
1108
Quarters > 1 > cash Flow > cash From Investing
-1108
Quarters > 1 > cash Flow > cash From Financing
-86632
Quarters > 1 > cash Flow > net Change In Cash
-11557
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
105.39669477422812
Quarters > 1 > ratios > ROA
-23.86273170112352
Quarters > 1 > ratios > FCF
73967
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.12873744467476683
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2007-12-31
Quarters > 2 > income Statement > revenue
1041304
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
1041304
Quarters > 2 > income Statement > operating Expenses
1799082
Quarters > 2 > income Statement > operating Income
-757778
Quarters > 2 > income Statement > interest Expense
167958
Quarters > 2 > income Statement > pretax Income
-939223
Quarters > 2 > income Statement > net Income
-939223
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-72.77202430798306
Quarters > 2 > income Statement > total Other Income Expense Net
-181445
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
52861
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1795264
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1987152
Quarters > 2 > balance Sheet > property Plant Equipment
56600
Quarters > 2 > balance Sheet > total Assets
4502925
Quarters > 2 > balance Sheet > payables
445161
Quarters > 2 > balance Sheet > short Term Debt
75621
Quarters > 2 > balance Sheet > long Term Debt
2396437
Quarters > 2 > balance Sheet > total Liabilities
4518434
Quarters > 2 > balance Sheet > equity
-15509
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-939223
Quarters > 2 > cash Flow > depreciation
209949
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-260757
Quarters > 2 > cash Flow > capital Expenditures
1108
Quarters > 2 > cash Flow > cash From Investing
-1108
Quarters > 2 > cash Flow > cash From Financing
-53565
Quarters > 2 > cash Flow > net Change In Cash
-314322
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
6055.986846347282
Quarters > 2 > ratios > ROA
-20.85806448031002
Quarters > 2 > ratios > FCF
-261865
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.2514779545646612
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2007-09-30
Quarters > 3 > income Statement > revenue
1168400
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
1168400
Quarters > 3 > income Statement > operating Expenses
1640389
Quarters > 3 > income Statement > operating Income
-471989
Quarters > 3 > income Statement > interest Expense
535859
Quarters > 3 > income Statement > pretax Income
-1232913
Quarters > 3 > income Statement > net Income
-1232913
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-40.39618281410476
Quarters > 3 > income Statement > total Other Income Expense Net
-760924
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
367183
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1943559
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2416260
Quarters > 3 > balance Sheet > property Plant Equipment
85019
Quarters > 3 > balance Sheet > total Assets
5127401
Quarters > 3 > balance Sheet > payables
414250
Quarters > 3 > balance Sheet > short Term Debt
3770641
Quarters > 3 > balance Sheet > long Term Debt
2605385
Quarters > 3 > balance Sheet > total Liabilities
5547849
Quarters > 3 > balance Sheet > equity
-420448
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1232913
Quarters > 3 > cash Flow > depreciation
20359
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-234574
Quarters > 3 > cash Flow > capital Expenditures
6180
Quarters > 3 > cash Flow > cash From Investing
237820
Quarters > 3 > cash Flow > cash From Financing
299521
Quarters > 3 > cash Flow > net Change In Cash
302767
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
293.23792716340665
Quarters > 3 > ratios > ROA
-24.045573966225774
Quarters > 3 > ratios > FCF
-240754
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.20605443341321467
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2007-12-31
Annuals > 0 > income Statement > revenue
5003690
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
5003690
Annuals > 0 > income Statement > operating Expenses
7757714
Annuals > 0 > income Statement > operating Income
-2754024
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-5483021
Annuals > 0 > income Statement > net Income
-5483021
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-55.03986058288983
Annuals > 0 > income Statement > total Other Income Expense Net
-2728997
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
52861
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1795264
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1987152
Annuals > 0 > balance Sheet > property Plant Equipment
56600
Annuals > 0 > balance Sheet > total Assets
4502925
Annuals > 0 > balance Sheet > payables
445161
Annuals > 0 > balance Sheet > short Term Debt
75621
Annuals > 0 > balance Sheet > long Term Debt
2396437
Annuals > 0 > balance Sheet > total Liabilities
4518434
Annuals > 0 > balance Sheet > equity
-15509
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-5483021
Annuals > 0 > cash Flow > depreciation
270022
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-1810461
Annuals > 0 > cash Flow > capital Expenditures
25764
Annuals > 0 > cash Flow > cash From Investing
252643
Annuals > 0 > cash Flow > cash From Financing
1480407
Annuals > 0 > cash Flow > net Change In Cash
-77411
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
35353.8010187633
Annuals > 0 > ratios > ROA
-121.76576336492391
Annuals > 0 > ratios > FCF
-1836225
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.3669741730602815
Annuals > 0 > health Score
40
Annuals > 1 > quarter
2006-12-31
Annuals > 1 > income Statement > revenue
5450997
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
5450997
Annuals > 1 > income Statement > operating Expenses
7348778
Annuals > 1 > income Statement > operating Income
-1897781
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-4083102
Annuals > 1 > income Statement > net Income
-4083102
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-34.81530076057646
Annuals > 1 > income Statement > total Other Income Expense Net
-2185321
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
130272
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1966791
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
2221218
Annuals > 1 > balance Sheet > property Plant Equipment
88920
Annuals > 1 > balance Sheet > total Assets
5231770
Annuals > 1 > balance Sheet > payables
516447
Annuals > 1 > balance Sheet > short Term Debt
3024982
Annuals > 1 > balance Sheet > long Term Debt
1997677
Annuals > 1 > balance Sheet > total Liabilities
4438272
Annuals > 1 > balance Sheet > equity
793498
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4083102
Annuals > 1 > cash Flow > depreciation
491194
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-836682
Annuals > 1 > cash Flow > capital Expenditures
1082
Annuals > 1 > cash Flow > cash From Investing
-1766834
Annuals > 1 > cash Flow > cash From Financing
2731582
Annuals > 1 > cash Flow > net Change In Cash
128066
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-514.5699170004209
Annuals > 1 > ratios > ROA
-78.04437121662458
Annuals > 1 > ratios > FCF
-837764
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.15369004972851755
Annuals > 1 > health Score
18
Annuals > 2 > quarter
2005-12-31
Annuals > 2 > income Statement > revenue
1090790
Annuals > 2 > income Statement > cost Of Revenue
103955
Annuals > 2 > income Statement > gross Profit
986835
Annuals > 2 > income Statement > operating Expenses
3612465
Annuals > 2 > income Statement > operating Income
-2521675
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-4645817
Annuals > 2 > income Statement > net Income
-4645817
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-231.1787786833396
Annuals > 2 > income Statement > total Other Income Expense Net
-2124142
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2206
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
310012
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
312218
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
1861066
Annuals > 2 > balance Sheet > payables
539806
Annuals > 2 > balance Sheet > short Term Debt
147681
Annuals > 2 > balance Sheet > long Term Debt
970282
Annuals > 2 > balance Sheet > total Liabilities
2562579
Annuals > 2 > balance Sheet > equity
-701513
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-4645817
Annuals > 2 > cash Flow > depreciation
184233
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-1144375
Annuals > 2 > cash Flow > capital Expenditures
1082
Annuals > 2 > cash Flow > cash From Investing
-675017
Annuals > 2 > cash Flow > cash From Financing
1820653
Annuals > 2 > cash Flow > net Change In Cash
1261
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
662.256722256038
Annuals > 2 > ratios > ROA
-249.6320388422549
Annuals > 2 > ratios > FCF
-1145457
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.0501168877602471
Annuals > 2 > health Score
40
Annuals > 3 > quarter
2004-12-31
Annuals > 3 > income Statement > revenue
465729
Annuals > 3 > income Statement > cost Of Revenue
106552
Annuals > 3 > income Statement > gross Profit
359177
Annuals > 3 > income Statement > operating Expenses
2961205
Annuals > 3 > income Statement > operating Income
-2495476
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-2644513
Annuals > 3 > income Statement > net Income
-2817159
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-535.8214755791458
Annuals > 3 > income Statement > total Other Income Expense Net
-149037
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
945
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
54841
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
78361
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
1045737
Annuals > 3 > balance Sheet > payables
366279
Annuals > 3 > balance Sheet > short Term Debt
782030
Annuals > 3 > balance Sheet > long Term Debt
400000
Annuals > 3 > balance Sheet > total Liabilities
2442942
Annuals > 3 > balance Sheet > equity
-1732111
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2817159
Annuals > 3 > cash Flow > depreciation
15246
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-1084592
Annuals > 3 > cash Flow > capital Expenditures
1082
Annuals > 3 > cash Flow > cash From Investing
-675017
Annuals > 3 > cash Flow > cash From Financing
1075328
Annuals > 3 > cash Flow > net Change In Cash
-9264
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
162.64309850812103
Annuals > 3 > ratios > ROA
-269.39459921567277
Annuals > 3 > ratios > FCF
-1085674
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.3311281882811676
Annuals > 3 > health Score
40
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
50.18173200350816
Profitability > metrics > ROA
-65.32249626882896
Profitability > metrics > Net Margin
-1.219335002958223
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-0.2867354777349656
Risk > final Score
29
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.5392580669249852
Liquidity > metrics > Quick Ratio
0.5392580669249852
Liquidity > final Score
37
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
28
Prev Risks > 1
12
Prev Risks > 2
26
Prev Liquidities > 0
52
Prev Liquidities > 1
100
Prev Liquidities > 2
39
Updated At
2026-01-20T21:30:51.632Z
Earnings History > 0 > period
2008-06-30
Earnings History > 0 > report Date
2008-09-03
Earnings History > 0 > date
2008-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.18
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.18
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2008-03-31
Earnings History > 1 > report Date
2008-04-16
Earnings History > 1 > date
2008-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-1.07
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-1.07
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2007-09-30
Earnings History > 2 > report Date
2007-11-15
Earnings History > 2 > date
2007-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-2.44
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-2.44
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2007-06-30
Earnings History > 3 > report Date
2007-08-17
Earnings History > 3 > date
2007-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-6.1
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-6.1
Earnings History > 3 > surprise Percent
-
Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABanyan Gold (CVE:BYN) Hits New 52-Week High – Here’s What Happened Defense World
Read more →Showing 2 of 10
(Last Updated 2008-06-30)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Banyan Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2008-06-30
EPS Actual
-0.18
EPS Estimate
0
EPS Difference
-0.18
Surprise Percent
0%
(Last Updated 2008-06-30)
(Last Updated 2008-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2008-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2008-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.